Quinolinyl and benzothiazolyl modulators
US7601841B2 · kind B2 · utility
14Cited by
75References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 20, 2003 |
| Grant date | Oct 13, 2009 |
| Priority date | — |
| Expiry date | Oct 11, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ. In particular, the compounds of the invention modulate the function of PPARγ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.